Petal study: safety, tolerability and effectiveness of elagolix, an oral GnRH antagonist for endometriosis

Reza Imani, R. Imani, Dao Thai-Cuarto, Roland Jimenez, Joshua Burke, Robin Kroll, Chris O’Brien
In: Fertility and Sterility · 2009 · vol. 92(3) , pp. S111–S112 · doi:10.1016/j.fertnstert.2009.07.1100 · W2023530725
article OA: closed CC0 ⤵ 6 in-corpus citations
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-10 ⓘ

This petal study evaluated the safety, tolerability, and effectiveness of elagolix, an oral gonadotropin-releasing hormone (GnRH) antagonist, in patients with endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

Cited by (6)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
unpaywall
last seen: 2026-09-11T06:32:28.951138+00:00
License: CC0 · commercial use OK